Clinical Trial

MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation

Name: MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation — clinical trial record (NCT07632157)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MAGNETIC-AF

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this research study is to find out if the use of magnesium in addition to Metoprolol, a rate controlling medication that you would be offered in the Emergency Department today unrelated to this study, will help reduce your high heart rate (rapid ventricular response).

Trial Details

NCT Number	NCT07632157
Lead Sponsor	Wake Forest University Health Sciences
Conditions	Atrial Flutter With Rapid Ventricular Response
Enrollment	196 participants
Start Date	2026-06
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-08